Breaking News

Rithem Life Sciences Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.

1st Patients Enrolled in STEM Trial for `Treatment of Chronic Subdural Hematoma

This marks the first patients enrolled in a prospective, randomized, international trial of a liquid embolic agent for the treatment of chronic subdural hematoma (cSDH), a common disease affecting primarily older adults.

Genius AI Detection Receives FDA Clearance – New Deep Learning-based Software Designed to Help Radiologists Detect Subtle Potential Cancers in Breast Tomosynthesis Images

This new technology, represents a pivotal milestone in the early detection of breast cancer, as studies showed Genius AI Detection software aids in the identification and early detection of breast cancer when used with the Genius® 3D Mammography™ exam.

Passio Pump Drainage System Granted 510(k) for Additional Indication for Home Use

The Passio Pump Drainage System consists of the Passio Catheter, a Handheld Control Unit (pump) and a Disposable Collection Kit, which includes a redressing kit, for drainage of recurrent and symptomatic pleural effusion.

Boston Scientific Signs Definitive Agreement to Divest BTG Specialty Pharmaceuticals Business

Boston Scientific notes SERB, backed by private equity firm Charterhouse Capital Partners since 2017, owns a diversified portfolio of prescription medicines focused on rare and life-threatening diseases.

Canon Medical Introduces New Configuration of Aquilion ONE / GENESIS Edition

Canon Medical notes to meet the growing cardiovascular imaging needs of healthcare systems, Canon Medical Systems USA, Inc. is introducing a new configuration of the Aquilion ONE / GENESIS Edition – the Aquilion ONE / GENESIS SP – a complete CT solution with proven cardiovascular capabilities. The Aquilion ONE / GENESIS SP was designed for the evolving needs of structural and coronary imaging, enabling consistent, high-quality studies through its AI-powered wide-area CT.

Canon Medical reports the Aquilion ONE / GENESIS SP enhances Canon Medical’s suite of Collaborative imaging tools which deliver clarity and confidence across the patient care cycle. Collaborative imaging provides a complete, integrated solution that helps medical practitioners address cardiovascular disease at every stage in the process — from evaluation to treatment, offering a wide range of features for complete cardiac care, including innovative CT technologies such as:

  • Improved diagnostic confidence across patients with one-beat, whole-heart acquisition and Advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR), which enables clinicians to obtain sharp, clear and distinct images.
  • Enhanced workflow capabilities because of automated tools from acquisition through analysis such as SURECardio and Vitrea Advanced Visualization, which can help clinicians manage their new increase in patient volume, and also deliver proven consistency in high image quality.
  • A lower total cost of ownership with a small footprint (204 square feet) that can fit into most existing CT rooms, unique scalability to fit varying technology needs and Power Save Mode improvements that enable the Aquilion ONE GENESIS / SP to require less cost to operate.
  • Patient-centric enhancements to help improve safety, comfort and access, including a wide bore (78 cm) and wide (47 cm) and low (33 cm) couch.

“Due to expanding applications of CT for structural heart procedures and coronary imaging, healthcare providers are growing their cardiac CT programs. At Canon Medical, we are committed to providing technologies that help clinicians keep pace with these evolving clinical pathways,” said Erin Angel, managing director, CT Business Unit, Canon Medical Systems USA, Inc. “Canon Medical’s CT product line, including the Aquilion ONE / GENESIS SP, is designed to offer complete cardiac capabilities. The platform was designed to be intuitive, making the acquisition of high-quality images easy and reliable across the full spectrum of patients and clinical scenarios.”

Canon Medical is showcasing the all-new Aquilion ONE / GENESIS SP and its full suite of innovative cardiac capabilities for high-quality routine cardiac imaging at this year’s virtual Society of Cardiac Computed Tomography (SCCT) annual meeting. Visit the booth here.

Latest Posts

Rithem Life Sciences Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.

1st Patients Enrolled in STEM Trial for `Treatment of Chronic Subdural Hematoma

This marks the first patients enrolled in a prospective, randomized, international trial of a liquid embolic agent for the treatment of chronic subdural hematoma (cSDH), a common disease affecting primarily older adults.

New England Biolabs Announces Further Expansion of Their RNA Depletion Product Portfolio with the Launch of the NEBNext Custom RNA Depletion Design Tool and NEBNext RNA Depletion Core Reagent...

Together, these enable a fully customizable workflow for improved removal of specific RNAs, including abundant RNAs such as ribosomal RNA

Don't Miss

New England Biolabs Announces Further Expansion of Their RNA Depletion Product Portfolio with the Launch of the NEBNext Custom RNA Depletion Design Tool and NEBNext RNA Depletion Core Reagent...

Together, these enable a fully customizable workflow for improved removal of specific RNAs, including abundant RNAs such as ribosomal RNA

INTERCEPT Blood System for Cryoprecipitation Receives FDA Approval States Cerus Corporation

The system is used to produce Pathogen Reduced Cryoprecipitated Fibrinogen Complex for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. 

Genetron Health Provides Update on HCCscreen™ for Liver Cancer Early Screening in China

Establishes joint venture with Wuxi municipal government; Expects the commercialization and revenues of HCCscreen to accelerate in China.

Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision

ProtoKinetix notes the research paper has been submitted to a prestigious journal specializing in tissue regeneration for peer review and editing.

OrganaBio to Expand Its cGMP Cell and Gene Therapy Manufacturing Facility: 19,000 Sq. Ft. Slated to Commence Operations In Q3 2021

OrganBio, a Miami-based cGMP facility, will include process development space, ISO 7 cleanrooms, state-of-the-art scientific equipment, analytics and QC laboratories, and a suite of support services to enable OrganaBio and its partners to rapidly and economically self-manufacture clinical materials.